Evidence map›Paper›PMID 32716982›Full record

SynthesisPloS one2020

Multidisciplinary care for opioid dose reduction in patients with chronic non-cancer pain: A systematic realist review.

Abhimanyu Sud, Alana Armas, Heather Cunningham, Shawn Tracy, Kirk Foat, Navindra Persaud, Fardous Hosseiny, Sylvia Hyland, Leyna Lowe, Erin Zlahtic and 6 more

Abstract readSystematic Review
In one paragraph

Synthesis in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Evaluations of Continuing Health Provider Education Focused on Opioid Prescribing: A Scoping Review.Academic medicine : journal of the Association of American Medical Colleges · 2022
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Abhimanyu SudDepartment of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-8354-6153
Alana ArmasBridgepoint Collaboratory for Research and Innovation, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Heather CunninghamGerstein Science Information Centre, University of Toronto, Toronto, Ontario, Canada.
Shawn TracyBridgepoint Collaboratory for Research and Innovation, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Kirk FoatIndependent Researcher, London, Ontario, Canada.
Navindra PersaudDepartment of Family and Community Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
Fardous HosseinyCanadian Mental Health Association National, Toronto, Ontario, Canada.
Sylvia HylandInstitute for Safe Medication Practices Canada, Toronto, Ontario, Canada.
Leyna LoweCanadian Mental Health Association National, Toronto, Ontario, Canada.
Erin ZlahticKinesiology, Western University, London, Ontario, Canada.
Rhea MurtiArts & Science, McMaster University, Hamilton, Ontario, Canada.
Hannah DeruePsychology, University of Guelph-Humber, Toronto, Ontario, Canada.
Ilana BirnbaumFaculty of Medicine, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-1306-915X
Katija BoninFaculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Ross UpshurBridgepoint Collaboratory for Research and Innovation, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Michelle L A NelsonBridgepoint Collaboratory for Research and Innovation, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.

Funding

CIHR OCK-156776
6 · The paper itself

Abstract

contextOpioid related deaths are at epidemic levels in many developed nations globally. Concerns about the contribution of prescribed opioids, and particularly high-dose opioids, continue to mount as do initiatives to reduce prescribing. Evidence around opioid tapering, which can be challenging and potentially hazardous, is not well developed. A recent national guideline has recognized this and recommended referral to multidisciplinary care for challenging cases of opioid tapering. However, multidisciplinary care for opioid tapering is not well understood or defined.

objectiveIdentify the existing literature on any multidisciplinary care programs that evaluate impact on opioid use, synthesize how these programs work and clarify whom they benefit. STUDY

designSystematic rapid realist review. DATASET: Bibliographic databases (MEDLINE, EMBASE, CINAHL, PsycINFO, Cochrane Library), grey literature, reference hand search and formal expert consultation.

results95 studies were identified. 75% of the programs were from the United States and the majority (n = 62) were published after 2000. A minority (n = 23) of programs reported on >12 month opioid use outcomes. There were three necessary but insufficient mechanisms common to all programs: pain relief, behavior change and active medication management. Programs that did not include a combination of all three mechanisms did not result in opioid dose reductions. A concerning 20-40% of subjects resumed opioid use within one year of program completion.

conclusionsProviding alternative analgesia is insufficient for reducing opioid doses. Even high quality primary care multidisciplinary care programs do not reduce prescribed opioid use unless there is active medication management accomplished by changing the primary opioid prescriber. Rates of return to use of opioids from these programs are very concerning in the current context of a highly potent and lethal street drug supply. This contextual factor may be powerful enough to undermine the modest benefits of opioid dose reduction via multidisciplinary care.

Indexed as

Interdisciplinary ResearchPatient CareAnalgesics, OpioidBehaviorChronic PainDose-Response Relationship, DrugHumansOutcome Assessment, Health CarePain ManagementPrimary Health CareTertiary Health CareTime FactorsAnalgesics, Opioid

Identifiers

PMID32716982
PMCPMC7384622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.